Form 4 for AMRX Amneal Pharmaceuticals, Inc.
Accepted 2026-09-02 17:03:34 ET · period of report 2026-09-01 · accession 0001628280-26-060179 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 17:03 | 2026-09-01 | AMRX | BOYER ANDREW S | EVP | G - Gift | $0.00 | -80.0K | 193.6K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-09-01 | G | D | 80,000 | $0.00 | 193,646 | D | — | — | (F1) Represents a gift to trust for the benefit of certain family members whereby reporting person does not serve as trustee. |